Hoth Therapeutics, Inc. (HOTH) Financials

HOTH Assets vs Liabilities

DateAssetsLiabilities
Sept. 30, 2023 12.1 million 1.6 million
June 30, 2023 11.9 million 2.0 million
March 31, 2023 13.5 million 1.6 million
Dec. 31, 2022 6.8 million 1.6 million

HOTH Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2023 -1.6 million 190265
June 30, 2023 -1.4 million 9748
March 31, 2023 -2.3 million 10630
Dec. 31, 2022 -2.6 million 15468

HOTH Net Income

No data available :(

HOTH Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2023 11.9 million - -
June 30, 2023 11.6 million - -
March 31, 2023 13.2 million - -
Dec. 31, 2022 6.6 million - -

HOTH Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2023 3.5 million
June 30, 2023 3.3 million
March 31, 2023 2.5 million
Dec. 31, 2022 1.2 million

HOTH Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2023 - 974374 1.1 million -
June 30, 2023 - 652202 1.1 million -
March 31, 2023 - 938878 1.3 million -
Dec. 31, 2022 7500 1.5 million 2.0 million -

HOTH Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2023 - 6752
June 30, 2023 - 7897
March 31, 2023 - 15120
Dec. 31, 2022 - 66834

HOTH

Price: $1.36

52 week price:
0.49
2.12

Earnings Per Share: -1.02 USD

P/E Ratio: -1.01

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 7144

Market Capitalization: 9.6 million

Links: